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Abstract.  The neurotrophin family includes NGF, 
brain-derived neurotrophic factor (BDNF), 
neurotrophin-3 (NT-3),  and neurotrophin-4 (NT-4). 
Previous studies have demonstrated that expression of 
NGF and its low-affinity receptor is induced in non- 
neuronal cells of the distal segment of the transected 
sciatic nerve suggesting a  role for NGF during axonal 
regeneration (Johnson, E.  M.,  M.  Taniuchi, and P.  S. 
DeStefano.  1988.  Trends Neurosci.  11:299-304).  To 
assess the role of the other neurotrophins and the 
members of the family of Trk signaling neurotrophin 
receptors,  we have here quantified the levels of 
mRNAs for BDNF, NT-3,  and NT-4 as well as 
mRNAs for trkA, trkB, and trkC at different times af- 
ter transection of the sciatic nerve in adult rats.  A 
marked increase of BDNF and NT-4 mRNAs in the 
distal segment of the sciatic nerve was seen 2  wk after 
the lesion. The increase in BDNF mRNA was medi- 
ated by a  selective activation of the BDNF exon IV 
promoter and adrenalectomy attenuated this increase 
by 50%.  NT-3 mRNA, on the other hand, decreased 
shortly after the transection but returned to control 
levels 2  wk later.  In Schwann Cells ensheathing the 
sciatic nerve, only trkB mRNA encoding truncated 
TrkB receptors was detected with reduced levels in the 
distal part of the lesioned nerve.  Similar results were 
seen using a probe that detects all forms of trkC 
mRNA.  In the denervated gastrocnemius muscle, the 
level of BDNF mRNA increased, NT-3 mRNA did not 
change, while NT-4 mRNA decreased. In the spinal 
cord, only small changes were seen in the levels of 
neurotrophin and trk mRNAs.  These results show that 
expression of mRNAs for neurotrophins and their Trk 
receptors is differentially regulated after a peripheral 
nerve injury. Based on these results a  model is 
presented for how the different neurotrophins could 
cooperate to promote regeneration of injured periph- 
eral nerves. 
S 
,CrlWANN cells in the distal part of the transected sci- 
atic nerve  secrete a  variety of factors that facilitate 
regeneration of the injured nerve fibers (Cajal,  1928; 
David and Aguayo, 1981; Fawcett and Keynes, 1990).  The 
best characterized of these factors is NGF, which in the pe- 
ripheral nervous system supports the survival of sympathetic 
and neural crest-derived sensory neurons (Levi-Montalcini, 
1987). NGF mRNA and protein are not detected in the intact 
adult rat sciatic nerve but their synthesis is markedly induced 
in nonneuronal cells of the distal segment of the axotomized 
nerve  (Heumann et al.,  1987a,b).  Similarly, the level  of 
mRNA for the low-affinity NGF receptor (p75N6FR)  ~ is in- 
Please address all correspondence to Dr.  H.  Funakoshi, Department of 
Medical Chemistry, Laboratory of Molecular Neurobiology,  Karolinska In- 
stitute,  Box 604 00, S-104 01, Stockholm, Sweden. 
The current address of Valerie M. K. Verge is the Department of Anat- 
omy, College of Medicine, Saskatoon,  SK,  Canada S7N OWO. 
tDr. H/ikan Persson deceased 16 May  1993. 
1. Abbreviations  used in this paper: BDNF, brain-derived neurotrophic fac- 
tor; DRG, dorsal root ganglia; IL-1/~, interleukin-1  beta; NT-3, neurotro- 
phin-3;  NT-4,  neurotrophin-4;  NT-4/5,  neurotrophin-4/5; p75  N°FR, the 
low-affinity NGF receptor; TrkA,  pl4Otrk; TrkB, p145trka; TrkC, p145  trkc. 
creased in nonneuronal cells in the distal segment of the in- 
jured nerve (Heumann et al., 1987b). The addition of  macro- 
phages, known to invade the site of injury in vivo, to cultured 
pieces of sciatic nerve induces NGF mRNA synthesis sug- 
gesting that the increase is mediated by factors secreted by 
macrophages (Heumann et al.,  1987b).  In agreement with 
this, recombinant interleukin-1  beta (IL-I~) increases NGF 
mRNA in nonneuronal cells of the rat sciatic nerve (Lind- 
holm et al.,  1987). 
The purification and molecular cloning of a second neuro- 
trophic factor, brain-derived neurotrophic factor (BDNF) 
(Barde et al., 1982; Leibrock et al., 1989) led to the discov- 
ery of a family of neurotrophic factors collectively known as 
the neurotrophins. Besides NGF and BDNF, the neurotro- 
phin family includes neurotrophin-3  (NT-3)  (Hohn et al., 
1990;  Maisonpierre  et  al.,  1990;  Ernfors  et  al.,  1990; 
Rosenthal  et  al.,  1990;  Kaisho  et  al.,  1990;  Jones  and 
Reichardt et al., 1990) and neurotrophin-4/5 (NT 4/5) (Hall- 
bffk et al., 1991; Berkemeier et al., 1991; Ip et al., 1992). 
The neurotrophins show ,,050% amino acid sequence identi- 
fies which are clustered in conserved regions intersected by 
variable regions, combinations of  which define the biological 
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survival of neurons in the sympathetic and nodose ganglia is 
promoted by specific neurotrophins, while all four neurotro- 
phins support the survival of embryonic sensory neurons in 
cell culture (Barde, 1989; Hohn et al., 1990; Maisonpierre 
et al., 1990; Hallb66k et al., 1991; Berkemeier et ai., 1991). 
All four neurotrophins bind to p75 NQ~ with similar affini- 
ties (Kd 10-gM) (Rodriguez-Tebar  et al.,  1990, 1992;  Ern- 
fors et al.,  1990;  Hallb/56k et al.,  1991). The specificity of 
the neuronal subpopulations responsive to the different neu- 
rotrophins is provided by the selective interaction between 
the different neurotrophins and members of the Trk family 
oftyrosine kinase receptors either alone (Klein et al., 1991a) 
or together with p75 NaFR (Hempstead et al.,  1991). NGF 
binds to and activates p140  ~k (herein called TrkA) (Kaplan 
et al.,  1991; Klein et al.,  1991a). BDNF and NT-4 interact 
with  p145  ~kB  (herein  called  TrkB)  (Soppet  et  al.,  1991; 
Squinto et al.,  1991; Klein et al., 1989, 1991b, 1992;  Ip et 
al., 1992),  while NT-3 interacts with p145  ~c (herein called 
TrkC)  and  to  a  lesser  extent  also  with  TrkA  and  TrkB 
(Cordon-Cardo et al., 1991; Lamballe et al., 1991; Klein et 
al.,  1991b; Squinto et al.,  1991). 
The sciatic nerve contains a mixture of sensory and motor 
axons and transection of the nerve increases the synthesis in 
the neuromuscular junction of acetylcholine receptors, the 
cell-adhesion molecule N-CAM and other proteins impor- 
tant for synaptogenesis (Changeux, 1991; Gatchalian et ai., 
1989;  Daniloff et al.,  1989).  Moreover, peripheral neurite 
outgrowth after injury is facilitated by the extracellular ma- 
trix, probably in particular laminin (Wang et al., 1992) and 
fibronectin, and the expression of fibronectin is increased in 
the Schwann cells after transection of  mature peripheral neu- 
rons (Lefcort et al.,  1992).  Target-derived trophic factors 
could also play a  role in the regenerative response and in 
agreement with this possibility, denervation of skeletal mus- 
cle induces neurite-outgrowth and survival-promoting ac- 
tivities for motoneurons in extracts of denervated muscle 
(Henderson et ai.,  1983;  Hill and Bennet,  1986;  Houenou 
et ai.,  1991). Interestingly, administration of BDNF to the 
transected sciatic or facial nerves in newborn rats prevents 
the death of the axotomized motoneurons (Yan et ai., 1992; 
Sendtner et al., 1992). Moreover, BDNF rescues in vivo de- 
veloping chick motoneurons from naturally occurring cell 
death (Oppenheim et al.,  1992).  Hence, certain neurotro- 
phins could function as target-derived neurotrophic factors 
for developing spinal cord motoneurons and promote sur- 
vival of motoneurons after injury. 
The aim of the present study was to obtain information on 
the role of the neurotrophins for regeneration of injured pe- 
ripherai nerves by first comparing the spatial and temporal 
expression of mRNAs for neurotrophins and trk receptors in 
muscle, sciatic nerve, and the spinal cord after transection 
of the sciatic nerve in adult rats. The results show that ex- 
pression of these mRNAs is differentially regulated in the 
three tissues and suggest that the neurotrophins could act in 
a concerted fashion, both locally within the lesioned nerve, 
and at a distance in the target-fields, to promote regeneration 
of peripheral nerves. 
Materials and Methods 
Animal Treatments and Surgery 
For transection of the sciatic nerve, adult male Sprague-Dawley rats (Alab, 
Sweden, 200-250 g body weight) were anesthetized with sodium pentobar- 
bital (50 mg/kg, i.p.) and both right and left sciatic nerves were transfected 
distal to the obturator tendon. Both the proximal and distal ends of the ax- 
otomized nerve were reflected to minimize nerve regeneration. This lesion 
is known to induce only a partial deficit in mobility of the lower limbs, al- 
lowing for free movement of the animal inside the cage. At the indicated 
times after axotomy, the animals were sacrificed by decapitation and the dis- 
tal and proximal segments (7-8 mm of each) of the sciatic nerve, the lum- 
bosacral part of the spinal cord and the gastrocnemius muscle were dis- 
sected. Where indicated, four different parts of the lesioned nerve were 
analyzed  (distal/distal,  distal/proximal,  proximal/distal,  and  proximal/ 
proximal) (see Fig. 8 A). For control, normal adult male Sprague-Dawley 
rats were sacrificed by decapitation and the dorsal root ganglia (DRG) (L4 
and L5), and the same tissues as above, were collected. All dissected  tissues 
were immediately frozen on dry ice and stored at -70"C before preparation 
of RNA. 
Adult male Sprague-Dawley rats were adrenalectomized bilaterally un- 
der pentobarbital anaesthesia. After adrenalectomy, the drinking water was 
supplemented with 3% saline to compensate for the loss of salt. Three days 
after the bilateral adrenalectomy, the right sciatic nerve was transected as 
described above. The animals were sacrificed 14 d after the axotomy and 
sciatic nerve segments were collected from both the control side (left side) 
and the axotomized side (right side). The tissues were immediately frozen 
on dry ice and stored at  -70°C before preparation of RNA. 
RNA Preparation 
Total  RNA from muscle and spinal cord was purified by the guanidine 
isothiocyanate/CsC1 method as described by Chirgwin et al. (1979).  Total 
RNA from the sciatic nerve and DRG was purified by the acid guanidine 
isothiocyanateJphenol-chloroform  extraction  method  as  described  by 
Chomczynski and Sacchi (1987).  The recovery of RNA was measured spec- 
trophotometrically. The quality and quantity was analyzed by electrophore- 
sis of 5 ttg RNA in a formaldehyde-containing 1% agarose gel stained with 
ethidium bromide, followed by UV illumination of the gel. 
RNAse Protection Analysis 
RNAse protection assays were performed with a R_PAIl[ Ribonuclease Pro- 
tection Assay Kit (Ambion,  Austin,  TX).  Anti-sense cRNA probes for 
BDNF and NT-4 were prepared as previously described (Timmusk et al., 
1993b).  To prepare the NT-3 antisense cRNA probe, a 320-bp EcoRV/ScaI 
fragment from a rat NT-3 cDNA clone (Ernfors et al., 1990) was inserted 
into pBSKS plasmid (Stratagene, La Jolla, CA). The construct was linear- 
ized with BamHI and transcribed with T3 RNA polymerase. The anti-sense 
cRNA probe detecting all TrkB transcripts was obtained by transcribing a 
linearized pBSKS plasmid containing a 485-bp insert encompassing nucleo- 
tides 1,030-1,515  in the rat trkB sequence of Middlemas et al. (1991). To 
prepare an anti-sense cRNA probe specific for mRNA encoding the full- 
length TrkB receptor, a 410-bp AvaI/AvaI fragment covering the protein 
tyrosine kinase domain of the TrkB receptor was inserted into pBSKS, lin- 
earized, and transcribed with T7 RNA polymerase. For the trkC antisense 
cRNA, a 438-bp fragment encompassing nucleotides 1,164-1,602  in the rat 
trkC sequence of Merlio et al. (1992) was cloned into pBSKS, linearized, 
and  transcribed  with  T7  RNA  polymerase.  Anti-sense cRNA  probes 
specific for rat BDNF exon I, II, III, and IV rnRNAs were prepared as previ- 
ously described (Timmusk et al.,  1993a).  All probes were labeled with 
c~-32p-CTP. The probes were hybridized at 45°C for 16 h to 10 or 20 t~g 
of total RNA from gastrocnemius muscle or 10/~g of total RNA from the 
indicated sciatic nerve segments, spinal cord, and DRG (L4 and LS) at the 
indicated time after axotomy. The assay was performed as described by the 
manufacturer. Protected cRNA fragments were separated on 4% polyacryl- 
amide gels under denaturating conditions and the gels were exposed to 
X-ray film at -70°C with intensifying screen. To quantify the relative levels 
of mRNAs for the neurotrophins and their Trk receptors in control and ax- 
otomized animals, only exposures within the linear range of the densitome- 
ter were used for analysis. The optical density values of the autoradiograms 
were measured by  image analysis using a  Dual-Wavelength  Flying-spot 
Scanner CS-9000 (Shimadzu Corporation, Kyoto, Iapan). The results are 
quantified relative to the same amount of total RNA from the mentioned 
tissues and therefore are independent of changes in cell number or size of 
tissue sample. 
In $itu Hybridization 
Synthetic  48-mer  oligonucleotides  complementary  to  mRNAs  for  rat 
p75 NoFn (Ernfors et al., 1989),  trkA, trk.B, and trkC (Merlio et al., 1993) 
were labeled at their 3' end with a-35S-dATP  (New England Nuclear, Bos- 
ton, MA) using terminal deoxynucleotidyltransferase (IBI) to a specific ac- 
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regions of these two mRNAs encoding parts of the extracellular and trans- 
membrane domains and therefore detect mRNAs encoding both truncated 
and full-length forms of these receptors (Middlemas  et al., 1991). Cryostat 
sections (14 t~m) were hybridized overnight at 42°C with 107 cpm of la- 
beled probe in 1 ml of  hybridization  solution as described previously (Verge 
et al., 1992). Control slides were hybridized as above in the presence of 
excess (400x) unlabeled probe or in the presence of an unrelated probe 
(growth hormone releasing factor). After hybridization, the slides were 
washed four times in lx SSC (0.15 M NaCI, 0.015 M sodium citrate, pH 
7.0) for 15 min at 55°C, rinsed briefly in distilled water, and dehydrated in 
ascending concentrations of ethanol. The sections were then dipped in Ko- 
dak NTB2 emulsion diluted 1:1 in distilled water and exposed in the dark. 
The sections were counter stained with toluidine blue. 
Results 
Expression of mRNAs for Neurotrophins and Members 
of the Trk Family after Transection of the Sciatic Nerve 
RNAse protection assays were used to quantify the relative 
levels of mRNAs  for  neurotrophins  and  Trk  receptors  at 
different times after transection of the sciatic nerve in adult 
rats. Three different tissues were included in the analysis: the 
gastrocnemius  muscle;  the  target-area  of the  axotomized 
motoneurons;  the distal and proximal segments  of the  le- 
sioned nerve; and the spinal cord containing the cell bodies 
of the axotomized motoneurons.  Two,  or where indicated, 
three independent experiments were performed and the rela- 
tive levels of mRNA were quantified by densitometric scan- 
ning of autoradiograms obtained after the hybridizations. 
Brain-derived Neurotrophic Factor 
In  the  gastrocnemius  muscle,  BDNF  mRNA  decreased 
slightly (,o40% lower than control) 6 and 12 h after the tran- 
section  but  reached  twofold  elevated  levels  one  and  two 
weeks after the transection (Fig.  1 A). 
Low levels of BDNF mRNA, close to the border of the de- 
tection limit, were seen in the intact adult rat sciatic nerve 
(Fig.  1 B).  An increase was seen in the distal segment one 
week after the lesion and sixfold higher levels were seen at 
2  wk compared to  1 wk after the lesion. 
Since  glucocorticoids  have  been  suggested  to  regulate 
BDNF mRNA expression in the brain (Barbany and Persson, 
1992),  we tested if the increase of BDNF mRNA in the le- 
sioned sciatic nerve was affected by adrenalectomy. Transec- 
tions in animals adrenalectomized three days before the ax- 
otomy resulted in a twofold decrease in BDNF mRNA in the 
distal segment of the injured nerve compared to transection 
in nonadrenalectomized animals (Fig. 1 B). The adrenalec- 
tomy alone did not change the expression of BDNF mRNA 
in the intact nerve. 
In the spinal cord, BDNF mRNA decreased slightly 6 and 
12  h  after  transection,  increased  by  ,o30%  at  3  d,  and 
declined to control level one week after the lesion (Fig. 1 C). 
The rat BDNF gene consists of four short 5'-exons and one 
3'-exon encoding the preproBDNF protein with a  separate 
promoter upstream of each 5'-exon (Timmusk et al., 1993a). 
The probe used in Fig.  1 is from the 3'-exon and therefore 
detects BDNF mRNAs transcribed from all four promoters. 
BDNF exon specific probes were used to determine if the in- 
crease of BDNF mRNA in the lesioned sciatic nerve was due 
to  a  differential activation of the  BDNF  promoters.  Only 
BDNF exon IV mRNA was detected in the distal part of the 
sciatic nerve two weeks after the transection (Fig. 2). 
Neurotrophin-3 
In the gastrocnemius muscle the level of NT-3 mRNA did not 
Figure 1. BDNF mRNA expression in gastrocnemius muscle (A), sciatic nerve (B), and spinal cord (C) after transection of the sciatic 
nerve in adult rats. Total cellular RNA (10 ~g for sciatic nerve and 20 #g for spinal cord and muscle) prepared at different times after 
transection of the adult rat sciatic nerve was hybridized to a 32p-labeled anti-sense BDNF cRNA probe. In the lesioned sciatic nerve, RNA 
was prepared from the distal segment of the nerve. RNAse protection assays were performed as described in Materials and Methods and 
the protected probe was electrophoresed in a denaturing acrylamide gel followed by exposure to X-ray film. Hybridization to tRNA was 
used as a negative control. The upper part of the figure shows autoradiograms obtained after the hybridizations. The autoradiograms were 
scanned in a densitometer and the optical density values were used to measure the relative levels of BDNF mRNA among the different 
samples. The levels of BDNF mRNA in the control gastrocnemius muscle and spinal cord were arbitrarily set at 100. For the sciatic nerve, 
the level of BDNF mRNA in the distal segment 2 wk after the transection was arbitrarily set at 100. All values are mean +  SEM of two 
independent experiments, cont, control; adx, RNA prepared from adrenalectomized animals; adx, axo, RNA prepared from the distal seg- 
ment of the transected sciatic nerve in adrenalectomized animals. 
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sected sciatic nerve. RNAse protection assays were performed with 
total RNA (10/~g) from control sciatic nerve (1, 4,  7, and 10) or 
from the distal segment of the adult rat sciatic nerve 2 wk after ax- 
otomy (2, 5, 8, and 11). Anti-sense cRNA probes specific for the 
indicated BDNF 5'-exons were used.  Hybridization to tRNA was 
used as a control (3, 6, 9, and 12). Arrow indicates the position of 
the protected  fragment using the exon IV specific probe. 
change at any of the time points tested after transection of 
the sciatic nerve (Fig.  3 A). 
In contrast to BDNF, NT-3 mRNA was clearly detected in 
the intact sciatic nerve from adult rats (Fig. 3 B). The level 
of NT-3 mRNA decreased ninefold in the distal segment of 
the lesioned nerve 6 and 12 h after the transection, and then 
returned progressively to control levels 2 wk after the injury. 
A biphasic response was seen in the spinal cord with a two- 
fold decrease 12 h after the lesion, a progressive increase to 
control level at three days followed by a twofold decrease at 
2  wk (Fig.  3  C). 
Neurotrophin-4 
NT-4 mRNA increased  approximately twofold in  the gas- 
trocnemius muscle 6 h after transection of the sciatic nerve 
but returned to control level 12 h after the lesion. A 4.5-fold 
decrease was seen at one day and the level decreased further 
reaching 11-fold lower than control 2 wk after the lesion (Fig. 
4 A). 
In the distal segment of the lesioned sciatic nerve, NT-4 
mRNA decreased 6 and 12 h after the axotomy but increased 
progressively thereafter with eightfold higher levels than in 
control 2  wk after the lesion (Fig.  4  B). 
In the spinal cord, a slight decrease was seen 6 h after the 
lesion returning to control levels at  12 h  (Fig.  4  C). 
TrkB 
Two different anti-sense cRNA probes were used to detect 
trkB  mRNA.  The  first  probe  is  complementary  to  trkB 
mRNA encoding part of the transmembrane and of the ex- 
tracellular domains  of the  TrkB receptor.  This probe (re- 
ferred to as the all trkB probe) detects trkB transcripts encod- 
ing both full-length and truncated TrkB receptors (Klein et 
al.,  1989;  Middlemas et al.,  1991).  The second trkB probe 
is from the part of the trkB sequence encoding the tyrosine 
kinase domain of the TrkB receptor and is therefore specific 
for trkB transcripts encoding a  full-length TrkB receptor. 
Both trkB probes revealed no, or only very low, levels of 
trkB mRNA in gastrocnemius muscle from intact or dener- 
vated animals (data not shown). 
In the intact and axotomized adult rat sciatic nerve, trkB 
transcripts were only detected with the all trkB probe. The 
level of all trkB transcripts in the proximal segment of the 
injured nerve increased progressively after the transection 
reaching twofold higher levels at one day followed by a de- 
cline to control levels at 3  d  (Fig.  5 A). 
In  the  spinal  cord,  the  full-length  trkB  probe  revealed 
slightly decreased levels of trkB transcripts 12 h and one day 
after the lesion. A  slight increase was seen at 3 d declining 
Figure 3. NT-3 mRNA expression in gastrocnemius muscle, (A) sciatic nerve (B), and spinal cord (C) after transection of the sciatic nerve 
in adult rats. RNAse protection assay was used to measure the level of NT-3 mRNA in the indicated samples as described in Fig.  1. The 
amount of NT-3 mRNA in the control samples was arbitrarily  set at 100. The values are mean 4- SEM from two (sciatic nerve) or three 
(muscle and spinal cord) independent experiments. 
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in adult  rats.  RNAse protection assays were used to measure the level of NT-4 mRNA in the indicated  samples  as described in Fig.  1. 
The level of NT-4 mRNA in control gastrocnemius muscle and spinal  cord were arbitrarily set at 100. For the sciatic nerve,  the level of 
NT-4 mRNA in the distal segment 2 wk after the transection was arbitrarily set at 100. The values are mean +  SEM of two (sciatic nerve 
and spinal  cord) or three (muscle)  independent  experiments. 
to control level 2  wk after the lesion (Fig.  5 B).  The level 
of all trkB mRNA decreased twofold one day after the tran- 
section with a twofold increase at 3 d followed by a threefold 
decrease 2  wk after the lesion (Fig.  5  C). 
Comparison of  AU trkB and Full-length trkB mRNA 
Expression in Neuronal and Nonneuronal Tissues 
Relatively high levels of all trkB mRNA were detected in all 
neuronal  and nonneuronal tissues  examined,  except in the 
gastrocnemius muscle where only low levels were seen.  In 
contrast,  full-length trkB mRNA was detected only in the 
neuronal  tissues,  spinal  cord,  and  the  dorsal  root ganglia 
(Fig.  6). 
TrkC 
The anti-sense  cRNA probe for trkC is complementary to 
trkC mRNA encoding part of the transmembrane and of the 
extracellular domains of the TrkC receptor and therefore de- 
tects trkC transcripts encoding both full-length and putative 
truncated  forms of the TrkC receptor. 
Figure 5. Expression of transcripts  encoding truncated and full-length  TrkB receptors in the sciatic  nerve and spinal cord after axotomy. 
RNAse protection assays were used to measure the level of trkB transcripts  encoding truncated and full-length  TrkB receptors in the indi- 
cated samples  as described in Fig.  1. (A) trkB truncated transcripts in the proximal  segment of the injured  sciatic  nerve,  trkB truncated 
(B) or full-length  (C) transcripts in the spinal cord. The amount of trkB transcripts  in the control samples  was arbitrarily set at 100. The 
values are mean  +  SEM from two independent experiments. 
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muscle, sciatic nerve, spinal cord, and DRG. RNAse protection as- 
says were performed using 10/~g of total RNA from the indicated 
tissues  dissected  form  nonoperated  adult  rats.  cRNA  probes 
specific  for mRNAs encoding full-length  TrkB  receptors  or all 
forms of TrkB receptors were used as described in Materials  and 
Methods.  (Skeletal  muscle) Normal gastrocnemius muscle, sciatic 
nerve; (normal  sciatic  nerve, spinal cord) normal lumbosacral part 
of spinal cord; (DRG) normal dorsal root ganglia  (L4 and L5). 
trkC probe revealed only very low levels of trkC mRNA 
in gastrocnemius muscle from intact or denervated animals 
(data not shown). 
In the proximal segment of the injured sciatic nerve, trkC 
mRNA decreased twofold 6  h  after the injury,  returned to 
control levels at one day,  with a  twofold increase at 2  wk 
(Fig.  7  A). 
In the spinal cord, trkC mRNA decreased twofold 12 h af- 
ter the axotomy, and then increased progressively to slightly 
higher levels compared to control at two weeks (Fig. 7 B). 
Regional Distribution of trkB and trkC mRNAs in the 
Axotomized Sciatic Nerve 
To determine  the distribution  of trkB and trkC mRNAs in 
Figure 8. (A) Schematic representation  of the location of different 
parts of the axotomized sciatic  nerve.  (a) Proximal/proximal  seg- 
ment;  (b)  proximal/distal  segment;  (c)  distal/proximal  segment; 
(d) distal/distal  segment.  (B) TrkB and (C) TrkC mRNA expres- 
sion in the sciatic nerve. (a) Proximal/proximal segment,  (b and b') 
proximal/distal  segment.  (c) Distal/proximal  segment;  (d) distal/ 
distal  segment;  a, b, c, and d are from the injured nerve 1 day (B) 
and 14 days (C) after the axotomy while b' is from the intact nerve. 
different parts of the transected sciatic nerve, four different 
segments of the lesioned sciatic nerve (Fig.  8 A) were ana- 
lyzed for all trkB and trkC mRNAs at one day and 2 wk after 
the lesion, respectively. For both mRNAs the highest levels 
Figure 7. trkC mRNA expression 
in  sciatic  nerve  (A)  and  spinal 
cord (B)  after axotomy.  RNAse 
protection  assays  were  used  to 
measure  the  level  of trkC  tran- 
scripts  encoding full-length  and 
putative  truncated  TrkC  recep- 
tors  in the indicated  samples  as 
described in Fig.  1. The amount 
of trkC mRNA  in  the  control 
samples  was  arbitrarily  set  at 
100. The values are mean ±  SEM 
of two  (sciatic  nerve)  or  three 
(spinal cord) independent experi- 
ments. 
The Journal of Cell Biology, Volume 123, 1993  460 Figure 9. Dark-field micrographs showing the detection of p75  N°~, trkA, trkB, and trkC mRNAs in the transected sciatic nerve by in situ 
hybridization.  The upper two rows show adjacent sections of the distal and proximal stump one week after the lesion. The lower two rows 
demonstrate the expression in adjacent sections distal and proximal to the nerve stump three weeks after the lesion. Low levels of p75  NGvR 
mRNA were detected proximal to the transection one and three weeks after the transection.  This was in contrast to the high expression 
in the distal denervated part of the nerve, trkA mRNA was not detected in the sciatic nerve at any time point, trkB and trkC mRNAs were 
detected in many cells in the sciatic nerve proximal to the transection.  Distal to the injury, trkB and trkC mRNAs were slightly decreased 
after one week, and had decreased to almost undetectable  levels after three weeks. Bar,  1,000/~m. Arrows point at the site of ligation. 
were  found  in  the  proximal/distal  and  proximal/proximal 
parts of the  axotomized nerve where the levels were  1.5- 
5-fold  higher  than  in  the  intact  nerve.  In  contrast,  both 
mRNAs decreased  in  the  distal/proximal and  distal/distal 
segments to levels significantly lower than in the intact nerve 
(Fig.  8, B  and  C). 
Cellular Localization of Neurotrophin Receptor 
mRNAs in the Injured Sciatic Nerve 
The expression of p75 N~, trkA, trkB,  and trkC mRNAs in 
the intact and axotomized sciatic nerve was also analyzed by 
in  situ  hybridization,  p75 N°n  and  trkA rnRNAs  were not 
detected in the intact sciatic nerve. In contrast, trkB and trkC 
mRNAs were detected at high levels in Schwann cells in the 
intact  nerve  (data  not  shown).  After  axotomy,  p75 NGFR 
mRNA  was  not  detected  in  the  proximal  segment of the 
sciatic nerve, except in Schwann cells close to the ligature 
(Fig. 9). These cells, as well as the majority of Schwann cells 
in  the  denervated  distal  sciatic  nerve  segment,  expressed 
high levels of p75  r~°~ mRNA one and three weeks after the 
lesion (Fig. 10). trkA mRNA was not detected in the injured 
sciatic nerve proximal or distal to the lesion. The levels of 
trkB and trkC mRNAs in Schwann cells proximal to the tran- 
section slightly increased to the levels in the intact nerve one 
week after the transection,  but decreased in the distal part 
of the nerve (Fig. 9). Analysis of emulsion autoradiographs 
revealed that in the proximal segment of the injured nerve the 
labeling for p75  s°~, trkB,  and trkC mRNAs were confined 
to Schwann cells (Fig.  10).  At three weeks, trkB and trkC 
mRNAs were still abundantly expressed proximal to the liga- 
ture.  In  contrast,  in  the  distal  segment,  trkB  and  trkC 
mRNAs decreased further at 3  wk to low or undetectable 
levels. All specific hybridization was abolished in the pres- 
ence of an excess of unlabeled probe, but no change was seen 
when an unrelated probe was used for competition. 
Discussion 
Expression of mRNAs for Neurotrophins and Trk 
Receptors in the Injured Sciatic Nerve 
The data presented here show that expression of neurotro- 
phin mRNAs is differentially regulated in the distal segment 
of the axotomized sciatic nerve in adult rats. Previous studies 
have shown a biphasic response in NGF mRNA with a rapid 
increase peaking at 6  h  after the lesion,  progressively in- 
Funakoshi et al. Neurotrophin  and irk mRNAs a~er Axotomy  461 Figure 10. Bright-field emulsion micrographs showing neurotrophin receptor mRNAs expression in the axotomized sciatic nerve proximal 
to a transection three weeks after the lesion by in situ hybridization, p75  NGva shows 1)75  N°~ mRNA, trkA shows trkA mRNA, trkB shows 
trkB mRNA, and trkC shows trkC mRNA expression.  No specific expression of p75  N°rR or trkA mRNA is seen,  but trkB and  trkC 
mRNAs were expressed at high levels in Schwann cells. Bar, 20 #m. 
creases and attains control levels by 2  wk after the lesion. 
NT-4 mRNA also decreases shortly after the lesion followed 
by a decline and a second peak 2-3 d later (Heumann et al., 
1987a).  In a recent study, Meyer et al. (1992) reported that 
BDNF mRNA increases in the distal part of the sciatic nerve 
one week after the lesion with progressively higher levels un- 
til 3 wk after the lesion.  Similar findings were seen in this 
study.  Our  results  also  show that  NT-3  mRNA decreases 
shortly after the lesion, progressively increases and attains 
control levels by 2 wk after the lesion. NT-4 mRNA also de- 
creases shortly after the lesion but reached greatly elevated 
levels 2  wk after the lesion. 
A comparison between the relative levels of BDNF, NT-3, 
and  NT-4 mRNAs in the  intact adult rat sciatic nerve re- 
vealed that the levels of mRNA for NT-3 were the highest, 
followed by NT-4 and BDNF mRNAs. The low, or undetect- 
able, levels of NGF and BDNF mRNAs could be due to a 
downregulation  of NGF and BDNF mRNA expression by 
axonal contact. 2 wk after the axotomy, the relative levels of 
neurotrophin mRNAs changed to the opposite relation seen 
in  the  intact  nerve,  i.e.,  BDNF  mRNA  levels  were  the 
highest while NT-3 mRNA levels were the lowest.  Similar 
to NGF mRNA (Heumann et al.,  1987a,b), NT-3 and NT-4 
mRNA showed a biphasic response to the axotomy with an 
early, acute response which was different from the second 
long-term response. In contrast, BDNF mRNA simply goes 
up from zero to a higher level at days 7 and  14.  The peak 
of NGF mRNA 2  d  after transection  of the  sciatic  nerve 
could be due to an inflammatory response mediated by mac- 
rophage released IL-lfl which stimulates NGF mRNA ex- 
pression in pieces of the sciatic nerve in culture (Lindholm 
et  al.,  1987).  Similarly,  an  inflammatory response could 
mediate the increases of BDNF, NT-3, and NT-4 mRNAs 2 
wk after the lesion. However, expression of BDNF mRNA 
in nerve organ cultures or in cultures of Schwann cells is not 
changed in response to IL-lfl indicating that different mecha- 
nisms  upregulate  NGF  and  BDNF  mRNA  in  the  sciatic 
nerve (Meyer et al.,  1992). 
The use of BDNF exon specific probes showed that only 
BDNF exon IV containing mRNA (Timmusk et al.,  1993a) 
was increased in the lesioned sciatic nerve suggesting that the 
induction  was due to a  selective activation of BDNF pro- 
moter IV. This promoter is preferentially used in peripheral 
tissues  (Timmusk et  al.,  1993a)  which  could explain the 
selective activation in nonneuronal cells in the distal segment 
of the lesioned nerve. 
Adrenalectomy attenuated the increase of BDNF mRNA 
in the lesioned nerve suggesting that glucocorticoids could 
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Figure 11.  Schematic  representation  of putative  neurotrophin- 
mediated trophic  supports for the injured peripheral  nerves.  The 
top panel sows the intact mature sciatic nerve with truncated TrkB 
receptors present on the surface of Schwann cells and full-length 
TrkB receptors in the neuron (sensory or motor). A similar scheme 
may apply to TrkC receptors.  Atrophic support is provided by the 
neurotrophin synthesized in the target-fields of  the neuron. Putative 
local autocrine/paracrine  modes of trophic interactions (not shown 
in the figure) could also apply, since BDNF and NT-3 mRNAs are 
expressed  in sensory neurons  in the  adult DRG (Ernfors  et al., 
1990b; Ernfors and Persson, 1991). After axotomy of the nerve, ex- 
pression of p75  N°n~, BDNF, and NT-4 is upregulated in Schwann 
cells  in the distal  segment of the  injured  nerve while the  TrkB 
receptor is downregulated  (see Figs. 8 and 9).  Elevated levels of 
BDNF and  NT-4 proteins  bind  to p75  N°FR, which  concentrates 
BDNF on the surface of the Schwann cells, presenting them to the 
fuU-length TrkB receptor in the proximal part of  the injured neuron. 
As regeneration proceeds (lower  panel), a target-derived  support 
could resume, enhanced by elevated levels of the neurotrophin  in 
the target-fields as a result of the lesion. This scheme may also ap- 
ply to NT-3 and TrkC receptors.  Note, however, that the levels of 
NT-3 mRNA did not change in the denervated muscle and NT-4 
mRNA decreased  in the muscle after the lesion,  arguing that the 
local trophic  support from the distal segment of the sciatic nerve 
is more important  for NT-3 and  NT-4. See text for further  dis- 
cussion. 
play a  role in  the upregulation  of BDNF  mRNA in  non- 
neuronal cells of the injured sciatic nerve. Similarly, gluco- 
corticoids have been suggested to regulate BDNF mRNA ex- 
pression  in  neurons  in  the  brain  (Barbany  and  Persson, 
1992).  Comparison of the rat BDNF gene sequence (Tim- 
musk et al.,  1993a) with known transcriptional regulatory 
sequences revealed a sequence element with high homology 
to a consensus binding site for the glucocorticoid receptor 
(AGAACAN3TGTTCT; Faisst and Meyer, 1992) 420 bp up- 
stream of the capsite in promoter IV. This sequence could 
function as a glucocorticoid responsive element that plays a 
role in the upregulation  of BDNF mRNA in the lesioned 
sciatic nerve. 
The  presence  of neurotrophin  receptors  in  the  injured 
sciatic nerve is a prerequisite for neurotrophin-mediated re- 
sponses  in  the  axotomized  nerve,  p75 s~FR mRNA  (Heu- 
mann et al.,  1987b) and immunoreactivity (Taniuchi et al., 
1986) increase markedly in the distal segment of the tran- 
sected sciatic nerve. After axonal contact during regenera- 
tion,  p75  N°~  expression is downregulated to the low level 
found in the intact sciaic nerve.  The induction  of p75  N6~ 
expression after the axotomy has been proposed as a mecha- 
nism to concentrate NGF on the surface of Schwann cells in 
the distal part, recruiting the ligand and thereby promoting 
nerve regeneration (Johnson et al., 1988). This model could 
be extended to include the other three neurotrophins,  since 
all  neurotrophins  bind  to  p75 N°n~ with  similar  affinities 
(Rodriguez-Tebar et al.,  1990,  1992;  Ernfors et al.,  1990; 
HallbO6k et al., 1991) and are all expressed in the distal part 
of the nerve after axotomy. Interestingly, the levels of trkB 
mRNA encoding truncated forms of the TrkB receptor was 
downregulated in Schwann cells associated with the distal 
segment of the transected nerve.  This result is in contrast 
with the increase in the levels of p75  N°~ (Taniuchi et al., 
1986; and this study), indicating that these two receptor mol- 
ecules have opposite regulations in Schwann cells of the dis- 
tal segment of the lesioned nerve.  The truncated  receptor 
lacks the tyrosine kinase domain and can therefore not medi- 
ate an intracellular signal (Klein et al.,  1991).  The role of 
the truncated TrkB receptor is not known, however the de- 
creased levels of truncated TrkB receptors in the distal part 
of the injured nerve could favor binding of BDNF or NT-4 
to an increased number of p75  N~FR which then recruits and 
presents these factors to full-length TrkB receptors present 
on the terminals of the axotomized neurons (Fig. 11) (Frisen 
et al.,  1993).  The level of BDNF mRNA increased in the 
gastrocnemius muscle 2 wk after denervation. This implies 
elevated levels of the BDNF protein also in the target-fields 
of axotomized motoneurons,  which could facilitate axonal 
guidance and regeneration (Fig. 11). Similar trophic interac- 
tions as outlined in Fig. 11 may also apply to NT-3, since two 
weeks after the lesion trkC transcripts decreased in the distal 
segment of the injured nerve. However, the probe used to de- 
tect trkC mRNA does not distinguish between transcripts for 
truncated or full-length receptors. The contribution of differ- 
ent forms of the TrkC receptor to this putative trophic sup- 
port can therefore not be evaluated from the present data. 
Expression of Neurotrophin and trk mRNAs in the 
Spinal Cord and Gastrocnemius Muscle 
BDNE NT-3, and NT-4 mRNAs were detected in the control 
adult rat spinal cord.  The cellular localization of neurotro- 
phin mRNAs in the spinal cord is not known. However, NT-3 
mRNA is expressed in embryonic rat spinal cord motoneu- 
rons (Ernfors and Persson, 1991; Schecterson and Bothwell, 
1992)  implying that NT-3 mRNA detected in the adult rat 
spinal cord could have been synthesized by motoneurons. 
NT-3 promotes the survival of proprioceptive sensory neu- 
rons in cell culture (Hohn et al.,  1990) and the finding of 
NT-3 mRNA in spinal cord motoneurons is consistent with 
the fact that NT-3 exerts a target-derived trophic support for 
these neurons.  The decreased level of NT-3 mRNA in the 
spinal cord 2 wk after transection of the sciatic nerve indi- 
cates that this trophic support is reduced after axotomy of the 
sciatic nerve. 
A  clear example of a differential regulation of neurotro- 
phin mRNA expression was seen in the gastrocnemius mus- 
cle  after denervation  caused by transection  of the  sciatic 
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sion, NT-3 mRNA did not change significantly,  while NT-4 
mRNA decreased eightfold 2 wk after the lesion. Recently, 
Koliatsos et al.  (1993)  also reported an increase of BDNF 
mRNA in the gastrocnemius muscle one week after a tran- 
section of the sciatic nerve.  The marked decrease of NT-4 
mRNA could indicate that the expression of NT-4 mRNA in 
skeletal  muscle  is  dependent  upon  neuronal  stimulation. 
BDNF has recently been shown to prevent the death of ax- 
otomized motoneurons in the sciatic and facial nerves (Yan 
et al., 1992;  Sendtner et al., 1992) and to rescue developing 
chick motoneurons  in  vivo  from naturally  occurring  cell 
death  (Oppenheim et al.,  1992).  Analysis of mRNA levels 
of RNAse protection assay has shown that BDNF mRNA is 
maximally expressed in skeletal muscle and skin in the early 
rat embryo (embryonic day  13) with decreasing amounts at 
later times of development (Timmusk et al., 1993b). This ex- 
pression pattern is consistent with the hypothesis that BDNF 
exerts a target-derived  trophic support for developing spinal 
cord motoneurons. A similar expression pattern was seen for 
NT-4 mRNA (Timmusk et al.,  1993b).  The increased level 
of BDNF mRNA after axotomy of the sciatic nerve in both 
the distal segment of the injured  nerve and in the gastroc- 
nemius muscle suggests that elevated levels of BDNF could 
promote regeneration of axotomized spinal cord motoneu- 
rons by both target-derived  and local modes of action (Fig. 
11). This effect would presumably be mediated by the acti- 
vation  of full-length TrkB receptors present on the surface 
of  the  axotomized  motoneurons  but  could  also  involve 
p75  N~FR, since expression of p75 r~rR mRNA is markedly up- 
regulated in spinal cord motoneurons after a crush lesion of 
the sciatic nerve (Ernfors et al., 1989,  1993). NT-3 is retro- 
gradely  transported  within  the  crushed  sciatic  nerve  to 
spinal cord motoneurons (DeStefano et al.,  1992)  and the 
findings  of NT-3 and trkC mRNAs in nonneuronal cells of 
the injured nerve and NT-3 mRNA in the denervated gastroc- 
nemius muscle suggest that NT-3 could promote the regener- 
ation  of axotomized  spinal  cord  motoneurons  by  similar 
mechanisms as proposed for BDNE  In the case of NT-4, a 
putative trophic support for spinal cord motoneurons is more 
likely to occur by a local mechanism, since NT-4 mRNA in- 
creased in the injured nerve but decreased markedly in the 
target area. 
In  summary,  the  changes  in  the  levels  of neurotrophin 
mRNAs  reported  here demonstrate that expression of not 
only NGF and BDNF but also of NT-3 and NT-4 mRNAs, 
is regulated  after a peripheral nerve injury. Our results are 
consistent with a model in which the altered levels of differ- 
ent  neurotrophin  and  Trk  receptor  proteins  after  lesion 
cooperate in sequential and concerted ways to enhance, both 
local and target-derived  trophic supports  important for the 
regeneration of injured peripheral neurons. 
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